Hence, our newly generated mouse model overexpressing meprin β in astrocytes cannot be considered as a classical AD mouse model due to the lack of amyloid plaque deposition and strong memory deficits, but it does show increased AD-like pathological APP processing and AD-associated behavior. This evidence concerns the gene MEP1B and Alzheimer disease.